Preoperative Memorial Sloan Kettering Prognostic Score and Long-Term Survival After Surgery for Early-Stage Gastric Cancer
The American Surgeon™ · 2026-12 · 92 (12) · 3139-3145
DOI: 10.1177/00031348261456686 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Surgeon™, online erschienen am 26.05.2026. Verfasst von Masayuki Urabe und 9 weiteren Autor:innen. Beteiligte Einrichtung: Gastrointestinal Surgery Division, Department of Surgery, Japanese Red Cross Omori Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Stomach Neoplasms, Gastrectomy. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Background
In early-stage gastric cancer (GC), survival is frequently determined not by tumor biology but by competing non-cancer-related risks, yet robust prognostic markers for this setting are lacking. We sought to determine whether the Memorial Sloan Kettering prognostic score (MPS) provides clinically meaningful prognostic information in patients with early GC.
Methods
We retrospectively analyzed 108 consecutive patients with pathological stage I GC who underwent curative surgical resection. The prognostic impact of preoperative MPS on overall survival (OS) was examined using Cox proportional hazards modeling.
Results
Over a median follow-up of 58 months, 26 deaths occurred, only one of which was cancer-related. Patients were stratified as MPS 0 (n = 56), MPS 1 (n = 45), and MPS 2 (n = 7). Preoperative MPS correlated significantly with age, sex, performance status, and Glasgow prognostic score (GPS). Preoperative MPS, but not GPS, significantly predicted OS on univariate analysis. On multivariate analysis, MPS emerged as a powerful, independent predictor of OS (MPS 1 vs 0: hazard ratio [HR] 3.64, 95% confidence interval [CI] 1.22-10.85; MPS 2 vs 0: HR 7.18, 95% CI 1.43-36.08; P = .031).
Discussion
Preoperative MPS robustly stratified mortality risk in patients undergoing curative surgery for early-stage GC. This finding may reposition MPS as a marker of global vulnerability and highlight its potential role in guiding risk-adapted surgical decision-making in GC population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gastrointestinal Surgery Division, Department of Surgery, Japanese Red Cross Omori Hospital, Tokyo, Japan.
ORCID-Profile: Masayuki Urabe
Zitieren
APA
Urabe, M., Suzuki, M., Fukai, T., Hasegawa, Y., Terai, E., Kiya, Y., Morizono, G., Hiyoshi, M., Watanabe, T., & Hashiguchi, Y. (2026). Preoperative Memorial Sloan Kettering Prognostic Score and Long-Term Survival After Surgery for Early-Stage Gastric Cancer. The American Surgeon™, 92(12), 3139-3145. https://doi.org/10.1177/00031348261456686
Vancouver
Urabe M, Suzuki M, Fukai T, Hasegawa Y, Terai E, Kiya Y, et al. Preoperative Memorial Sloan Kettering Prognostic Score and Long-Term Survival After Surgery for Early-Stage Gastric Cancer. The American Surgeon™. 2026;92(12):3139-3145. doi:10.1177/00031348261456686
BibTeX
@article{Urabe2026,
author = {Urabe, Masayuki and Suzuki, Mami and Fukai, Takahiro and Hasegawa, Yui and Terai, Emi and Kiya, Yoshitaka and Morizono, Goki and Hiyoshi, Masaya and Watanabe, Toshiyuki and Hashiguchi, Yojiro},
title = {Preoperative Memorial Sloan Kettering Prognostic Score and Long-Term Survival After Surgery for Early-Stage Gastric Cancer},
journal = {The American Surgeon™},
year = {2026},
volume = {92},
number = {12},
pages = {3139--3145},
doi = {10.1177/00031348261456686}
}
EUVIMED